Fund Times: ICAP Funds and RS Investments Acquired
Plus, PIMCO's commodity transition, Putnam manager change, and more.
New York Life Investment Management has announced that it is acquiring Institutional Capital Corporation (ICAP), a superb Chicago-based money manager. ICAP's three mutual funds will join New York Life's MainStay fund family, and ICAP will likely subadvise other MainStay funds.
Despite posting stellar track records on funds like ICAP Select Equity (ICSLX) and ICAP International (ICEUX), for which ICAP president and chief portfolio manager Rob Lyon and his team won Morningstar's 2005 International-Stock Manager of the Year award, ICAP's funds are still quite small. The shop's funds, which have roughly $2 billion in assets among them, will now be distributed by New York Life's considerable sales force. ICAP's principals, including Lyon and Jerry Senser, have signed employment contracts with New York Life for an unknown length of time. When the merger is complete, current shareholders in ICAP funds will hold no-load I shares and will continue to pay 0.80%. But new load share classes will be rolled out. New York Life owns other small asset managers, such as MacKay Shields and McMorgan.
Lawrence Jones does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.